Pharma Fine Chemical Industries Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 17-07-2024
- Paid Up Capital ₹ 6.97 M
as on 17-07-2024
- Company Age 45 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.67 M
as on 17-07-2024
- Revenue 28.52%
(FY 2023)
- Profit -10.10%
(FY 2023)
- Ebitda -22.64%
(FY 2023)
- Net Worth 3.87%
(FY 2023)
- Total Assets -0.63%
(FY 2023)
About Pharma Fine Chemical Industries
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.97 M.
The company has closed loans amounting to ₹1.67 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shyam Khadria, Pradeep Tiwary, and Sunil Singh serve as directors at the Company.
- CIN/LLPIN
U24230BR1979PTC001424
- Company No.
001424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 1979
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Begusarai, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharma Fine Chemical Industries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Khadria  | Director | 28-Jun-2019 | Current |
| Pradeep Tiwary | Director | 15-Nov-2012 | Current |
| Sunil Singh | Director | 15-Nov-2012 | Current |
Financial Performance of Pharma Fine Chemical Industries.
Pharma Fine Chemical Industries Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.52% increase. The company also saw a substantial fall in profitability, with a 10.1% decrease in profit. The company's net worth moved up by a moderate rise of 3.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Fine Chemical Industries?
In 2023, Pharma Fine Chemical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shankar Motors Private LimitedActive 67 years 11 monthsShyam Khadria and Pradeep Tiwary are mutual person
Maurya Motors Private LimitedActive 34 years 1 monthShyam Khadria and Pradeep Tiwary are mutual person
Shankar Equipments LimitedActive 37 years 5 monthsShyam Khadria and Pradeep Tiwary are mutual person
- Kunal Automobiles Private LimitedActive 36 years 9 months
Shyam Khadria and Pradeep Tiwary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Mar 1983 | ₹0.50 M | Satisfied |
State Bank Of India Creation Date: 07 Mar 1983 | ₹1.17 M | Satisfied |
How Many Employees Work at Pharma Fine Chemical Industries?
Unlock and access historical data on people associated with Pharma Fine Chemical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Fine Chemical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Fine Chemical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
